The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Nanoparticles – known and unknown health risks
Hoet, P. H., Brüske-Hohlfeld, I., & Salata, O. V. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-12 · Cited by 1,374
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
(2016) · Wiley eBooks · doi:10.1002/9781119000822 · Cited by 1,148
Singh, R., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., & Kostarelos, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509009103 · Cited by 1,043
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
Cited by
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
Manufacturing challenges and rational formulation development for AAV viral vectors
Srivastava, A., Mallela, K. M. G., Deorkar, N., & Brophy, G. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.03.024 · Cited by 269
Non-invasive monitoring of interstitial fluid lactate through an epidermal iontophoretic device
De la Paz, E., Saha, T., Del Caño, R., Seker, S., Kshirsagar, N., & Wang, J. (2023) · Talanta · doi:10.1016/j.talanta.2022.124122 · Cited by 63
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Metadata
- Authors
- Psimadas, D., Georgoulias, P., Valotassiou, V., & Loudos, G.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 101
- Issue
- 7
- Pages
- 2271-2280
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2157736127
- Cited by
- 322
- References
- 56
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles. https://app.cochat.ai/papers/10.1002/jps.23146
- The paper
- Psimadas, D., Georgoulias, P., Valotassiou, V., & Loudos, G. (2012). Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.23146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.